Skip to main content

Part of the book series: NATO ASI Series ((NSSA,volume 152))

  • 79 Accesses

Abstract

In order to image the distribution of spread of metastases from a primary adenocarcinoma in a patient using radioimmunoscintigraphy, a combination of four factors is required: an antibody specific to the cancer in question; a radiolabel that is optimal for the imaging system and for the kinetics of antibody uptake; a method of labeling the antibody and quality control so that is is suitable for injection into the patient; and, a gamma camera imaging system that enables the distribution of the radiolabeled antibody to be visualized to the best advantage. Although it is evident that the major limitation of the current practice of radioimmunoscintigraphy is the inability to get sufficient numbers of a sufficiently specific antibody on to all the cancer cells that have spread from the primary site, this paper is concerned with the other three requirements: the radiolabel, the labeling method, and the imaging of its distribution, with particular reference to the use of iodine-123.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Berche, C., Mach, J.P., Lambroso, J.D., Langlais, C., Aubry, F., Buchegger, F., Carrel, S., Rouigier, P., Parmentier, D., and Tubiana, M., 1982, Tomoscintigraphy for detection of gastrointestinal and medullary thyroid cancers. First clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Brit. Med. J., 285: 1447.

    Article  CAS  Google Scholar 

  • Bett, R., Cuninghame, J. G., Hill, J.I.S., Jones, I.G., Taylor, N.K., and Winter, J.A., 1980, Development of a process for routine production of I-125 using the I-127 (p, 5n) 123-Xe→123-I reaction. J. Radioanal. Chem. 56: 237.

    Article  CAS  Google Scholar 

  • Buraggi, G.L., Turrin, A., Cascinelli, N., Attili, A., Terno, G., Bombardierei, E., Gasparini, M., and Seregni, E., 1985, Immunoscintigraphy with antimelanoma monoclonal antibodies. In: “Immunoscintigraphy” L. Donato & K.E. Britton, Eds. 215–253, Monographs in Nuclear Medicine Volume 1, P. Cox, Ed. Gordon & Breach, London.

    Google Scholar 

  • Davies, J.O., Davies, E.R., Howe, K., Jackson, P.C., Pitcher, E.M., Sadowski , C.S.. Stirrat, G.M., and Sunderland, C.A., 1985, Radionuclide imaging of ovarian -tumours with I-123 labelled monoclonal antibody. Brit. J. Obstet. Gynaecol. 92:277.

    Article  CAS  Google Scholar 

  • Epenetos, A.A., Britton, K.E., Mather, S., Shepherd, J., Granowska, M., Taylor-Papadimitriou, J., Nimmon, C.C., Durbin, H., Hawkins, L.A., Malpas, J.S., and Bodmer, W.F., 1982, Targetting of Iodine-123 labelled tumour associated monoclonal antibodies to ovarian, breast and intestinal tumours. Lancet, ii:999.

    Article  Google Scholar 

  • Fraker, P.J., and Speek, J.C., 1978, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1, 3, 4, 6-tetra-chloro-3a, 6a-diphenylglycoluril. 80:849.

    CAS  Google Scholar 

  • Goldman, A., Vivian, G., Gordon, I., Pritchard, J., and Kemshead, J.T., 1984, Immunolocalisation of neuroblastoma using radiolabelled monoclonal antibody UJ13A. J. Paediat. 105:252.

    Article  CAS  Google Scholar 

  • Granowska, M., and Britton, K.E., 1986c, A strategic approach to radio-immunoscintigraphy in ovarian and colorectal cancer. In: “Radioaktive isotope in klinik und forschung” Vol. 17, 377–381. Gasteimer Int. Symp. 1986, R. Hofer and H. Bergman, Eds. Egermann Verlag, Vienna.

    Google Scholar 

  • Granowska, M., Britton, K.E., Shepherd, J., 1984a, The detection of ovarian cancer using I-123 monoclonal antibody. Radiobiol. Radiother. (Berl) 25: 153.

    CAS  Google Scholar 

  • Granowska, M., Britton, K.E., Shepherd, J.H., Nimmon, C.C., Mather, S., Ward, B., Osborne, R.J., and Slevin, M.L., 1986b, A prospective study of I-123 labelled monoclonal antibody imaging in ovarian cancer. J. Clin. Onc. 4: 730.

    CAS  Google Scholar 

  • Granowska, M., Nimmon, C.C. and Britton, K.E., 1986a, Immunoscintigraphy of ovarian cancer by means of HMFG2 monoclonal antibody. In: “Nuclear medicine in clinical oncology”, 171–174, C. Winkler, Ed. Springer-Verlag, Berlin.

    Chapter  Google Scholar 

  • Granowska, M., Shepherd, J., Britton, K.E., Ward, B., Mather, S., Taylor-Papadimitriou, J., Epenetos, A.A., Carroll, M.J., Nimmon, C.C., Hawkins, L.A., Flatman, W.D., Home, T., and Bodmer, W.F., 1984b, Ovarian cancer: diagnosis using 123-I monoclonal antibody in comparison with surgical findings. Nucl. Med. Commun. 5:485.

    Article  PubMed  CAS  Google Scholar 

  • Home, T., Granowska, M., Dicks-Mireaux, C., Hawkins, L.A., Britton, K.E., Mather, S., Bomanji, J., Kemshead, J.T., Kingston, J., and Malpas, J.S., 1985, Neuroblastoma imaged with I-123 meta iodo benzyl guanidine and with I-123 labelled monoclonal antibody, UJ13A, against neural tissue. Brit. J. Radiol., 58: 476.

    Article  Google Scholar 

  • Miller, W.T., and Smith, J.F.G., 1983, Protein iodination using iodogen. Int. J. Appl. Radiat. Isot., 34: 639.

    Article  Google Scholar 

  • Ott, R.J., Grey, L.J., Zivanovic, M.A., Flower, M.A., Trott, N.G., Moshakis, V., Coombes, R.C., Neville, A.M., Ormerod, M.G., and Westwood, J.H., 1983, The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine labelled antibodies. Brit. J. Radiol., 56: 101.

    Article  PubMed  CAS  Google Scholar 

  • Pateisky, N., Philipp, K., Skodler, W.D., Czerwenka, K., Hamilton, G., and Burchell, J., 1985, Radioimmunodetection in patients with suspected ovarian cancer. J. Nucl. Med., 26: 1369.

    PubMed  CAS  Google Scholar 

  • Taylor-Papadimitriou, J., Peterson, J.A., Arklie, J., Burchell, J., Ceriani, R.C., and Bodmer, W.F., 1981, Monoclonal antibodies to epithelium specific components of the human milk fat globulin membrane: production and reaction with cells in culture. Int. J. Cancer, 28: 17.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer Science+Business Media New York

About this paper

Cite this paper

Britton, K., Granowska, M. (1988). Experience with Iodine-123 Labeled Antibodies. In: Srivastava, S.C. (eds) Radiolabeled Monoclonal Antibodies for Imaging and Therapy. NATO ASI Series, vol 152. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5538-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5538-0_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5540-3

  • Online ISBN: 978-1-4684-5538-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics